Advertisement

Pediatric Graft-Versus-Host Disease

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Ophthalmology and Optometry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Jacobsohn D.A.
        Optimal management of chronic graft-versus-host disease in children: Review.
        Br J Haematol. 2010; 150: 278-292
        • Baird K.
        • Cooke K.
        • Schultz K.R.
        Chronic graft-versus-host disease (GVHD) in children.
        Pediatr Clin North Am. 2010; 57: 297-322
        • Hoehn M.E.
        • Vestal R.
        • Calderwood J.
        • et al.
        Ocular complications in school-age children and adolescents after allogeneic bone marrow transplantation.
        Am J Ophthalmol. 2020; 213: 153-160
        • Hoehn M.E.
        • Calderwood J.
        • Gannon E.
        • et al.
        Ocular complications in a young pediatric population following bone marrow transplantation.
        J Am Assoc Pediatr Ophthalmol Strabismus. 2018; 22: 102-106.e1
        • Vriesendorp H.M.
        • Heidt P.J.
        History of graft-versus-host disease.
        Exp Hematol. 2016; 44: 674-688
        • Fung S.S.
        • Elbaz U.
        • Mireskandari K.
        • et al.
        Graft versus host disease: a pediatric perspective.
        Expert Rev Ophthalmol. 2019; 14: 89-99
        • Filipovich A.H.
        • Weisdorf D.
        • Pavletic S.
        • et al.
        National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report.
        Biol Blood Marrow Transplant. 2005; 11: 945-956
        • Riemens A.
        • te Boome L.
        • Imhof S.
        • et al.
        Current insights into ocular graft-versus-host disease.
        Curr Opin Ophthalmol. 2010; 21: 485-494
        • Zecca M.
        Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome.
        Blood. 2002; 100: 1192-1200
        • Inagaki J.
        • Moritake H.
        • Nishikawa T.
        • et al.
        Long-term morbidity and mortality in children with chronic graft-versus-host disease classified by national institutes of health consensus criteria after allogeneic hematopoietic stem cell transplantation.
        Biol Blood Marrow Transplant. 2015; 21: 1973-1980
      1. Transplant Activity Report. Center for International Blood and Marrow Transplant, a contractor for the C.W. Bill Young Cell Transplantation Program operated through the U. S. Department of Health and Human Services, Health Resources and Services Administration. Healthcare Systems Bureau, 2021
      2. Nicholas GA, Carl R. Ocular manifestations of graft versus host disease. Current Opinion in Ophthalmology 2004, 15(6):503-7.

        • Ansari M.
        • Petrykey K.
        • Rezgui M.A.
        • et al.
        Genetic susceptibility to acute graft versus host disease in pediatric patients undergoing HSCT.
        Bone Marrow Transplant. 2021; 56: 2697-2704
        • Jagasia M.H.
        • Greinix H.T.
        • Arora M.
        • et al.
        National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report.
        Biol Blood Marrow Transplant. 2015; 21: 389-401.e1
        • Liu Y.M.
        • Hockenberry M.
        Review of chronic graft-versus-host disease in children after allogeneic stem cell transplantation: nursing perspective.
        J Pediatr Oncol Nurs. 2011; 28: 6-15
      3. Zeiser R, Blazar BR. Pathophysiology of chronic graft-versus-host disease and therapeutic targets. Longo DL, ed. N Engl J Med. 2017;377(26):2565-2579.

        • Kondo M.
        • Kojima S.
        • Horibe K.
        • et al.
        Risk factors for chronic graft-versus-host disease after allogeneic stem cell transplantation in children.
        Bone Marrow Transpl. 2001; 27: 727-730
        • Lee J.W.
        • Lee D.H.
        • Jang P.S.
        • et al.
        Prognostic Implications of the NIH Consensus Criteria in Children with Chronic Graft-versus-Host Disease.
        Yonsei Med J. 2011; 52: 779
        • Hirst L.
        • Jabs D.
        • Tutschka P.
        • et al.
        The Eye in Bone Marrow Transplantation: I. Clinical Study.
        Arch Ophthalmol. 1983; 101: 580-584
        • Sun Y.C.
        • Chai X.
        • Inamoto Y.
        • et al.
        Impact of ocular chronic graft-versus-host disease on quality of life.
        Biol Blood Marrow Transplant. 2015; 21: 1687-1691
        • Inamoto Y.
        • Valdés-Sanz N.
        • Ogawa Y.
        • et al.
        Ocular graft-versus-host disease after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.
        Bone Marrow Transpl. 2019; 54: 662-673
        • Jabs D.
        • Wingard J.
        • Green W.
        The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease.
        Arch Ophthalmol. 1989; 107: 1343-1348
        • Blackburn R.
        • Mueller B.
        • Ramasubramanian A.
        A stepwise approach to the ocular manifestations of graft-vs.-host disease.
        EyeNet Magazine, 2017
        • Lawitschka A.
        • Ball L.
        • Peters C.
        Nonpharmacologic treatment of chronic graft-versus-host disease in children and adolescents.
        Biol Blood Marrow Transplant. 2012; 18: S74-S81
        • Pathak M.
        • Diep P.P.
        • Lai X.
        • et al.
        Ocular findings and ocular graft-versus-host disease after allogeneic stem cell transplantation without total body irradiation.
        Bone Marrow Transpl. 2018; 53: 863-872
        • Ogawa Y.
        • Kim S.K.
        • Dana R.
        • et al.
        International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: Proposed Diagnostic Criteria for Chronic GVHD (Part I).
        Sci Rep. 2013; 3: 3419
        • Wolffsohn J.S.
        • Arita R.
        • Chalmers R.
        • et al.
        TFOS DEWS II Diagnostic Methodology report.
        Ocul Surf. 2017; 15: 539-574
        • Robinson M.R.
        • Lee S.S.
        • Rubin B.I.
        • et al.
        Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease.
        Bone Marrow Transpl. 2004; 33: 1031-1035
        • Hébert M.
        • Archambault C.
        • Doyon C.
        • et al.
        Risk factors for ocular involvement in pediatric graft-versus-host disease.
        Cornea. 2021; 40: 1158-1164
        • Hamilton B.K.
        Current approaches to prevent and treat GVHD after allogeneic stem cell transplantation.
        Hematology. 2018; 2018: 228-235
        • O’Neil E.C.
        • Henderson M.
        • Massaro-Giordano M.
        • et al.
        Advances in dry eye disease treatment.
        Curr Opin Ophthalmol. 2019; 30: 166-178